Trip.com Group Ltd. ADR (0I50)
London Exchange · UK · prices in USD · close of 15 Oct 2026
Key indicators
| Last close | USD 39.40 |
|---|---|
| 52-week range | 37.58 – 78.85 |
| Return, 1 month / 3 months | −0.7% / −8.0% |
| Return, 1 year / 3 years | −43.9% / +9.5% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 43.4% |
| Worst drawdown (1 year) | -51.7% |
| Average daily value traded | 0.18M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Trip.com Group is an online travel services company based in Shanghai, China. It runs travel booking platforms that let customers reserve hotels, flights, train tickets and attraction passes, and it also provides packaged tours and travel-related services. Its customers are mainly leisure and business travellers, and it serves markets across China and internationally through its various travel brands. The company earns revenue from booking commissions and related travel services.
The shares are listed on the London Exchange in UK under the code 0I50, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Trip.com Group Ltd. ADR (0I50) trades on the London Exchange in UK. It last closed at USD 39.40 on 15 October 2026.
Its price-based Market X-Ray is 22 out of 100 (a weak price profile), ranking 3,376 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 43.9% and over the last three months it fell 8.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 13 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -21.3% | ||
| From 52-week high | -49.5% | ||
| Momentum | 18 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.0% | ||
| 6-month return | -24.8% | ||
| 12-month return, skipping the last month | -43.6% | ||
| Stability (higher is calmer) | 27 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -51.7% | ||
| Liquidity | 36 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.18M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +4.5% |
|---|---|
| 1 month | −0.7% |
| 3 months | −8.0% |
| 6 months | −24.8% |
| 1 year | −43.9% |
| 3 years | +9.5% |
| 5 years | +9.5% |
Signals
| 50-day / 200-day average | 42.01 / 50.10 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 1.04 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Mar 2025 | SGD 0.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.